GB202110721D0 - Treatment and prevention of alcoholic liver disease - Google Patents

Treatment and prevention of alcoholic liver disease

Info

Publication number
GB202110721D0
GB202110721D0 GBGB2110721.4A GB202110721A GB202110721D0 GB 202110721 D0 GB202110721 D0 GB 202110721D0 GB 202110721 A GB202110721 A GB 202110721A GB 202110721 D0 GB202110721 D0 GB 202110721D0
Authority
GB
United Kingdom
Prior art keywords
prevention
treatment
liver disease
alcoholic liver
alcoholic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2110721.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Universitaet Innsbruck
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaet Innsbruck, Boehringer Ingelheim International GmbH filed Critical Universitaet Innsbruck
Priority to GBGB2110721.4A priority Critical patent/GB202110721D0/en
Publication of GB202110721D0 publication Critical patent/GB202110721D0/en
Priority to EP22760659.7A priority patent/EP4376948A1/en
Priority to JP2024503869A priority patent/JP2024526944A/en
Priority to PCT/EP2022/070974 priority patent/WO2023006765A1/en
Ceased legal-status Critical Current

Links

GBGB2110721.4A 2021-07-26 2021-07-26 Treatment and prevention of alcoholic liver disease Ceased GB202110721D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB2110721.4A GB202110721D0 (en) 2021-07-26 2021-07-26 Treatment and prevention of alcoholic liver disease
EP22760659.7A EP4376948A1 (en) 2021-07-26 2022-07-26 Treatment and prevention of alcoholic liver disease
JP2024503869A JP2024526944A (en) 2021-07-26 2022-07-26 Treatment and prevention of alcoholic liver disease
PCT/EP2022/070974 WO2023006765A1 (en) 2021-07-26 2022-07-26 Treatment and prevention of alcoholic liver disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2110721.4A GB202110721D0 (en) 2021-07-26 2021-07-26 Treatment and prevention of alcoholic liver disease

Publications (1)

Publication Number Publication Date
GB202110721D0 true GB202110721D0 (en) 2021-09-08

Family

ID=77541054

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2110721.4A Ceased GB202110721D0 (en) 2021-07-26 2021-07-26 Treatment and prevention of alcoholic liver disease

Country Status (1)

Country Link
GB (1) GB202110721D0 (en)

Similar Documents

Publication Publication Date Title
GB202005097D0 (en) Treatment and/or prevention of covid-19 infection
EP4054713A4 (en) Compositions and methods for treatment or prevention of skin diseases and disorders with lekti
IL282251A (en) Compositions and methods for treatment of liver disease
EP4188346A4 (en) Nobiletin compositions and methods for the treatment and prevention of covid-19 and related pathologies
EP4225923A4 (en) Compositions and methods for the prevention and/or treatment of covid-19
IL290891A (en) Compositions and methods of treating vascular diseases
EP4171606A4 (en) Compositions and methods for the treatment of covid-19
IL275925A (en) Prevention and treatment of organ fibrosis
EP3913002A4 (en) Application of ecm1 in prevention and/or treatment of liver fibrosis-related diseases
GB202013874D0 (en) Treatment and prevention of viral infections
GB202110862D0 (en) Treatment and prevention of alcoholic liver disease
GB202110721D0 (en) Treatment and prevention of alcoholic liver disease
IL312583A (en) Composition for treatment and prevention of covid-19
EP4238567A4 (en) Novel treatment and prevention of sarcopenia-related diseases
IL218467A0 (en) Picrorhiza kurroa extract for prevention elimination and treatment of infection diseases
EP4088735A4 (en) Application of cst1 in prevention and/or treatment of liver immune dysregulation diseases
IL311698A (en) Methods of treating cancer and the pharmaceutical compositions thereof
EP2054080A4 (en) Treatment and prevention of allergic airways diseases
GB202103578D0 (en) Prevention and treatment of infections including those caused by coronavirus
GB201908544D0 (en) Treatment and prevention of disease mediated by wwp2
EP3917619A4 (en) Structurally modified opioids for prevention and treatment of diseases and conditions
GB202002030D0 (en) Treatment and prevention of metabolic diseases
GB202001896D0 (en) Treatment and prevention of metabolic diseases
GB202001013D0 (en) Treatment and prevention of metabolic diseases
GB201906597D0 (en) Treatment and prevention of metabolic diseases

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH

Free format text: FORMER OWNERS: BOEHRINGER INGELHEIM INTERNATIONAL GMBH;MEDIZINISCHE UNIVERSITAT INNSBRUCK

AT Applications terminated before publication under section 16(1)